The LC–MS/MS analysis was performed on neuronal Tau from transgenic mice expressing the mutation TauA152T (a risk factor for progressive supranuclear palsy (26)) purified by immunoprecipitation using the TauA152T specific antibody 1C5. Here, MAPT is linked to Classical progressive supranuclear palsy.